Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
European Intravitreal Avastin Trial 1
2005-003132-21Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab in age-related macular degeneration (AMD) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Visual acuity (ETDRS). Started Aug 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2005-003132-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003132-21.